Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2026 Results: May 7, 2026PRNewsWire • 04/01/26
Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure SystemPRNewsWire • 03/30/26
What Investors Should Know About a $24 Million Exit From a Medical Device Stock Down 9% This Past YearThe Motley Fool • 03/20/26
Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS TechnologyPRNewsWire • 02/23/26
Haemonetics to Present at Raymond James 47th Annual Institutional Investors ConferencePRNewsWire • 02/20/26
Haemonetics (HAE) Reports Q3 Earnings: What Key Metrics Have to SayZacks Investment Research • 02/05/26
Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Available on Investor Relations WebsitePRNewsWire • 02/05/26
Haemonetics Corporation (HAE) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/13/26
Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by HaemoneticsGlobeNewsWire • 01/12/26
Will Haemonetics (HAE) Beat Estimates Again in Its Next Earnings Report?Zacks Investment Research • 01/09/26